At Philip Morris International Inc. (PMI), our ambition is that all those who would otherwise continue to smoke switch as soon as possible to better alternatives and abandon cigarettes to the benefit of their health, public health and society at large. PMI’s cutting-edge research is used to develop products with the potential to significantly reduce the risks of continued smoking. We continue to explore how our knowledge and expertise in consumer insight, inhalation technology, toxicology, product development and consumer digital applications can be applied to the development of future innovations.

PM Equity Partner is interested in speaking with companies that are involved in respiratory delivery, botanical sciences, health monitoring technologies as well as computational research methodologies and other innovations that have the potential to benefit individual and public health.